Home Cart Sign in  
Chemical Structure| 1448232-80-1 Chemical Structure| 1448232-80-1

Structure of Naquotinib
CAS No.: 1448232-80-1

Chemical Structure| 1448232-80-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Naquotinib is an irreversible mutant EGFR inhibitor with potential antineoplastic activity.

Synonyms: ASP8273

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Naquotinib

CAS No. :1448232-80-1
Formula : C30H42N8O3
M.W : 562.71
SMILES Code : O=C(C1=NC(CC)=C(O[C@H]2CN(C(C=C)=O)CC2)N=C1NC3=CC=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)N
Synonyms :
ASP8273
MDL No. :MFCD30496701
InChI Key :QKDCLUARMDUUKN-XMMPIXPASA-N
Pubchem ID :71667668

Safety of Naquotinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Naquotinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02192697 Non-small Cell Lung Cancer PHASE1|PHASE2 TERMINATED 2017-06-14 Site: 4, Fukuoka, Japan|Site: ... More >>9, Fukuoka, Japan|Site: 8, Miyagi, Japan|Site: 7, Okayama, Japan|Site: 3, Osaka, Japan|Site: 6, Osaka, Japan|Site: 2, Shizuoka, Japan|Site: 1, Tokyo, Japan|Site: 5, Tokyo, Japan|Site: 10, Seoul, Korea, Republic of|Site: 11, Seoul, Korea, Republic of|Site: 12, Seoul, Korea, Republic of|Site: 13, Taipei, Taiwan|Site: 14, Taipei, Taiwan Less <<
NCT03042013 Subjects With NSCLC With an EG... More >>FR Activating Mutation Less << PHASE2 WITHDRAWN 2017-02-28 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.89mL

1.78mL

0.89mL

17.77mL

3.55mL

1.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories